Singapore, March 11 -- Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnostics and therapeutics, has announced two supply contracts that mark its strategic expansion into the East and Southeast Asian region.

South Korean startup Lunit will supply its Lunit INSIGHT CXR for chest abnormality detection and Lunit INSIGHT MMG for mammography analysis to the Chung Shan Medical University (CSMU) in Taiwan and Gleneagles Hospital in Singapore, respectively. Gleneagles plans to enhance screening accuracy and operational efficiency by seamlessly integrating Lunit's cutting-edge technology into its breast screening workflow.

Compared to Taiwan's current screening programme, which relies on low-dose comput...